A novel protein glycan biomarker and LCAT activity in metabolic syndrome

GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation

(2015) J. D. Otvos et al.   CLINICAL CHEMISTRY

Alterations in plasma lecithin:cholesterol acyltransferase and myeloperoxidase in acute myocardial infarction: Implications for cardiac outcome

(2014) Robin P.F. Dullaart et al.   ATHEROSCLEROSIS

GLYCA AND GLYCB, NOVEL NMR BIOMARKERS OF INFLAMMATION, STRONGLY PREDICT FUTURE CARDIOVASCULAR EVENTS, BUT NOT THE PRESENCE OF CORONARY ARTERY DISEASE (CAD), AMONG PATIENTS UNDERGOING CORONARY ANGIOGRAPHY: THE INTERMOUNTAIN HEART COLLABORATIVE STUDY

(2014) J. Brent Muhlestein et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events

(2014) Akintunde O. Akinkuolie et al.   Journal of the American Heart Association

Increased Serum Cholesterol Esterification Rates Predict Coronary Heart Disease and Sudden Death in a General Population

(2013) Shin-ichiro Tanaka et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Assessing the functional properties of high-density lipoproteins: an emerging concept in cardiovascular research

(2013) Michela Triolo et al.   Biomarkers in Medicine

Glycosylation of Serum Proteins in Inflammatory Diseases

(2013) Olga Gornik et al.   DISEASE MARKERS

The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects

(2013) Robin P. F. Dullaart et al.   Obesity

Recombinant human lecithin-cholesterol acyltransferase Fc fusion: Analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region

(2013) Chris Spahr et al.   PROTEIN SCIENCE

Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment

(2013) E. S. Collins et al.   RHEUMATOLOGY

Metabolic Signatures of Insulin Resistance in 7,098 Young Adults

(2012) P. Wurtz et al.   DIABETES

Circulating Metabolite Predictors of Glycemia in Middle-Aged Men and Women

(2012) P. Wurtz et al.   DIABETES CARE

Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?

(2012) Sandra Kunnen et al.   JOURNAL OF LIPID RESEARCH

Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome

(2011) Paul Jan Willem Herman Kappelle et al.   ARCHIVES OF MEDICAL RESEARCH

Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease

(2011) Laura Calabresi et al.   ATHEROSCLEROSIS

Lecithin Cholesterol Acyltransferase: An Anti- or Pro-atherogenic Factor?

(2011) Xavier Rousset et al.   Current Atherosclerosis Reports

Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL

(2011) Paul J. W. H. Kappelle et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals

(2011) Christiane L. Haase et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Plasma lecithin:cholesterol acyltransferase and carotid intima-media thickness in European individuals at high cardiovascular risk

(2011) Laura Calabresi et al.   JOURNAL OF LIPID RESEARCH

The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins

(2011) Soumaya Loued et al.   LIFE SCIENCES

C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians

(2011) Elizabeth B. Windgassen et al.   POSTGRADUATE MEDICINE

A systematic approach to protein glycosylation analysis: a path through the maze

(2010) Karina Mariño et al.   Nature Chemical Biology

High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol

(2009) Robin P.F. Dullaart et al.   ATHEROSCLEROSIS

Plasma lecithin:cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men

(2009) R.P.F. Dullaart et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

HDL as a Biomarker, Potential Therapeutic Target, and Therapy: FIG. 1.

(2009) Mohamad Navab et al.   DIABETES

Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study

(2009) M. Jacobs et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

A catalogue of reporting guidelines for health research

(2009) I. Simera et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study

(2009) A. G. Holleboom et al.   JOURNAL OF LIPID RESEARCH

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

(2009) E. Maury et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Plasma Lecithin: Cholesterol Acyltransferase Activity Is Elevated in Metabolic Syndrome and Is an Independent Marker of Increased Carotid Artery Intima Media Thickness

(2008) Robin P. F. Dullaart et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Beyond High-Density Lipoprotein Cholesterol Levels

(2008) Emil M. deGoma et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation

(2008) James N. Arnold et al.   PROTEOMICS